Grandfield & Dodd LLC purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 71,975 shares of the semiconductor company's stock, valued at approximately $32,106,000. Synopsys accounts for approximately 1.7% of Grandfield & Dodd LLC's investment portfolio, making the stock its 15th biggest position.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of SNPS. Sankala Group LLC acquired a new position in Synopsys in the 4th quarter valued at $25,000. Elevation Wealth Partners LLC lifted its stake in shares of Synopsys by 96.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock worth $25,000 after acquiring an additional 27 shares during the period. IMG Wealth Management Inc. purchased a new stake in shares of Synopsys in the second quarter valued at about $28,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Synopsys in the fourth quarter valued at about $28,000. Finally, Atlas Capital Advisors Inc. purchased a new stake in shares of Synopsys in the fourth quarter valued at about $32,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Synopsys Stock Performance
Shares of SNPS opened at $413.22 on Tuesday. The company has a 50-day simple moving average of $424.42 and a 200-day simple moving average of $442.30. The company has a quick ratio of 1.32, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $79.12 billion, a PE ratio of 95.65, a P/E/G ratio of 2.48 and a beta of 1.23. Synopsys, Inc. has a 52-week low of $366.00 and a 52-week high of $626.24.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping analysts' consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the previous year, the firm earned $3.67 earnings per share. The firm's revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Equities research analysts predict that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several research firms recently issued reports on SNPS. Rosenblatt Securities increased their price target on shares of Synopsys from $530.00 to $575.00 and gave the stock a "buy" rating in a report on Tuesday, May 26th. Morgan Stanley lifted their price objective on Synopsys from $480.00 to $525.00 and gave the company an "equal weight" rating in a report on Thursday, May 28th. Benchmark began coverage on Synopsys in a research report on Wednesday, July 15th. They set a "buy" rating and a $570.00 target price on the stock. KeyCorp reissued an "overweight" rating on shares of Synopsys in a research note on Thursday, May 28th. Finally, Wells Fargo & Company cut their target price on Synopsys from $535.00 to $450.00 and set an "equal weight" rating for the company in a research note on Tuesday, August 11th. Two investment analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $565.06.
Check Out Our Latest Analysis on SNPS
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 3,394 shares of the firm's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the transaction, the chief financial officer directly owned 14,358 shares of the company's stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm's stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares of the company's stock, valued at $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by company insiders.
Synopsys Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
